Ribosomal protein L6 pseudogene 16 (RPL6P16)

Ribosomal protein L6 pseudogene 16 is a processed pseudogene derived from the *RPL6* gene, which encodes 60S ribosomal protein L6, a component of the large ribosomal subunit involved in protein synthesis[1][3][7]. Pseudogenes such as RPL6P16 are nonfunctional genetic elements that result from the duplication or retrotransposition of functional genes[7]. They do not produce a functional protein, typically lack biological function, and are not implicated as therapeutic targets. RPL6P16 is one of many processed ribosomal protein pseudogenes dispersed throughout the human genome[3][7]. Key context: - *RPL6* itself encodes a structural component of ribosomes[1][2][5]. The pseudogene RPL6P16, however, only shares sequence similarity with the parental gene but does not encode an active protein. - Pseudogenes, in general, are usually not transcribed or translated, and they lack known direct roles in disease, drug response, or biological pathways[3][7]. There is no evidence from current biological or pharmacological literature that RPL6P16 is utilized as a drug target, biomarker, or has any therapeutic relevance. RPL6P16 is most accurately described as a *genomic artifact* or nonfunctional pseudogene[7][3].

Other names

RPL6_12_538RPL6P16